Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05524649

Effect of Probiotics on Infant's Fecal Microbiota Composition

Safety, Tolerability and Effect on Fecal Microbiota Composition of Two Probiotic Strains in Infants

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
AB Biotics, SA · Industry
Sex
All
Age
1 Day – 90 Days
Healthy volunteers
Accepted

Summary

Randomized clinical trial to evaluate the effect of two probiotic strains which belong to Bifidobacterium Longum and Pediococcus pentosaceus species on fecal microbiota composition in healthy infants. Secondary outcomes comprise evaluation of anthropometric growth, digestive tolerance, sleeping habits, incidence of functional gastrointestinal disorders, incidence of gastrointestinal and respiratory infections, allergic reactions and safety and tolerability of the product.

Detailed description

Double-blind, randomized, placebo-controlled clinical trial to determine the effect of the probiotic strains Bifidobacterium longum and Pediococcus pentosaceus on fecal microbiota composition in infants. Healthy babies with ages comprised between 60 and 90 days who meet inclusion and exclusion criteria will be randomized 1:1:1 to one of the following study groups: one group will receive Bifidobacterium longum, another group will receive Pediococcus pentosaceus and the other one will receive placebo for 3 months. Other study outcomes comprise anthropometric growth, frequency and consistency of the stools, digestive tolerance, wellbeing, number, type and duration of infections and functional gastrointestinal disorders, and adverse events.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFood Supplement 1Probiotic single strain formulation containing Bifidobacterium longum CECT7894 for 3 months 5 drops/day
DIETARY_SUPPLEMENTFood Supplement 2Probiotic single strain formulation containing Pediococcus pentosaceus CECT8330 for 3 months 5 drops/day
DIETARY_SUPPLEMENTPlacebo5 drops/day for 3 months of sunflower oil

Timeline

Start date
2022-06-01
Primary completion
2025-08-31
Completion
2025-12-31
First posted
2022-09-01
Last updated
2025-02-11

Locations

2 sites across 2 countries: Mexico, Spain

Source: ClinicalTrials.gov record NCT05524649. Inclusion in this directory is not an endorsement.